The ECHELON core team has done
this before. Repeatedly.

The ECHELON team blends extensive experience in crucial areas to create innovative medical technology ventures and commercial successes. Unlike many start-ups, this team knows how to develop, commercialize, launch and generate returns (and exits) from medical devices and digital health solutions.

Established in 2020, ECHELON is a spin-out of BioGenerator, the investment arm of BioSTL. Our shared mission is to de-risk and accelerate medical innovations for commercial readiness, for partnering with or acquisition by medical device market leaders, and for contracting opportunities with the military.

  • Military medical product research, development, and acquisiton
  • Clinical development of neurosurgical medical devices
  • Commercialization, strategic marketing, and demand creation
  • Generation of investment capital and shareholder return